Zhe Xu
Bayer (United States)(US)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Health Systems, Economic Evaluations, Quality of Life, Diabetes, Cardiovascular Risks, and Lipoproteins, Nutritional Studies and Diet, Health Promotion and Cardiovascular Prevention
Most-Cited Works
- → SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe(2021)1,513 cited
- → SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions(2021)550 cited
- → SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe(2023)268 cited
- → Diet quality, change in diet quality and risk of incident CVD and diabetes(2019)103 cited
- → Dietary Cholesterol Intake and Sources among U.S Adults: Results from National Health and Nutrition Examination Surveys (NHANES), 2001–2014(2018)79 cited
- → Prediction of Cardiovascular Disease Risk Accounting for Future Initiation of Statin Treatment(2021)38 cited
- → Preoperative anemia as a prognostic factor in patients with lung cancer: a systematic review and meta-analysis of epidemiological studies(2019)24 cited
- → Dietary phosphorus intake and blood pressure in adults: a systematic review of randomized trials and prospective observational studies(2018)20 cited
- → Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2)(2022)18 cited
- → Using Polygenic Risk Scores for Prioritizing Individuals at Greatest Need of a Cardiovascular Disease Risk Assessment(2023)13 cited